HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The structure-hemolysis relationship of oleanolic acid derivatives and inhibition of the saponin-induced hemolysis with sapogenins.

Abstract
Chikusetsusaponin IV and V, whose genin is oleanolic acid, exhibited weak hemolytic activities. Removal of glucose residue at position 29 of chikusetsusaponin V by partial hydrolysis increased the activity more than 30-fold. Methylation of the carboxyl group at position 28 increased the activity furthermore by about 10-fold, showing HD50 value of 3.77 microM. On the other hand, removal of the sugar chain at position 3 of chickusetsusaponin V by partial hydrolysis completely lost the activity. These facts suggest that the sugar chain at position 3 of oleanolic acid is essential but that at position 29 is pernicious for the activity. The cytolytic agents, whose target has been regarded as membrane cholesterol, were inactivated not only by cholesterol but also by sapogenins such as oleanolic acid, gitogenin and hederagenin. Among saponins tested, akebia saponin B and C were inactivated by cholesterol, but not by the genins, probably because their affinities for the genins are too low to form complexes.
AuthorsJ Hase, K Kobashi, K Mitsui, T Namba, M Yoshizaki, T Tomimori
JournalJournal of pharmacobio-dynamics (J Pharmacobiodyn) Vol. 4 Issue 11 Pg. 833-7 (Nov 1981) ISSN: 0386-846X [Print] Japan
PMID7328484 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Sapogenins
  • Saponins
  • Oleanolic Acid
  • Cholesterol
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Chemical Phenomena
  • Chemistry
  • Cholesterol (pharmacology)
  • Hemolysis (drug effects)
  • Humans
  • In Vitro Techniques
  • Oleanolic Acid (analogs & derivatives, pharmacology)
  • Panax
  • Plants, Medicinal
  • Sapogenins (pharmacology)
  • Saponins (antagonists & inhibitors)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: